My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 289

    1.

    Telmisartan shows an equivalent effect of vitamin C in further improving endothelial dysfunction after glycemia normalization in type 1 diabetes.

    Ceriello A, Piconi L, Esposito K, Giugliano D.

    Diabetes Care. 2007 Jul;30(7):1694-8. Epub 2007 Apr 24.PMID: 17456844 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Simultaneous control of hyperglycemia and oxidative stress normalizes endothelial function in type 1 diabetes.

    Ceriello A, Kumar S, Piconi L, Esposito K, Giugliano D.

    Diabetes Care. 2007 Mar;30(3):649-54.PMID: 17327335 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes.

    Ceriello A, Esposito K, Ihnat M, Thorpe J, Giugliano D.

    J Clin Endocrinol Metab. 2009 Aug;94(8):2751-6. Epub 2009 Jun 2.PMID: 19491221 [PubMed - indexed for MEDLINE]Related articles

    4.

    Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in Type II diabetes.

    Darko D, Dornhorst A, Kelly FJ, Ritter JM, Chowienczyk PJ.

    Clin Sci (Lond). 2002 Oct;103(4):339-44.PMID: 12241530 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus.

    Evans M, Anderson RA, Smith JC, Khan N, Graham JM, Thomas AW, Morris K, Deely D, Frenneaux MP, Davies JS, Rees A.

    Eur J Clin Invest. 2003 Mar;33(3):231-8.PMID: 12641541 [PubMed - indexed for MEDLINE]Related articles

    6.

    High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance.

    Chen H, Karne RJ, Hall G, Campia U, Panza JA, Cannon RO 3rd, Wang Y, Katz A, Levine M, Quon MJ.

    Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H137-45. Epub 2005 Aug 26.PMID: 16126809 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.

    Neri S, Signorelli SS, Torrisi B, Pulvirenti D, Mauceri B, Abate G, Ignaccolo L, Bordonaro F, Cilio D, Calvagno S, Leotta C.

    Clin Ther. 2005 Nov;27(11):1764-73.PMID: 16368447 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of vitamin E and C supplementation combined with oral antidiabetic therapy on the endothelial dysfunction in the neonatally streptozotocin injected diabetic rat.

    Alper G, Olukman M, Irer S, Cağlayan O, Duman E, Yilmaz C, Ulker S.

    Diabetes Metab Res Rev. 2006 May-Jun;22(3):190-7.PMID: 16216038 [PubMed - indexed for MEDLINE]Related articles

    9.

    Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetes.

    Anderson RA, Evans LM, Ellis GR, Khan N, Morris K, Jackson SK, Rees A, Lewis MJ, Frenneaux MP.

    Diabet Med. 2006 Mar;23(3):258-64.PMID: 16492208 [PubMed - indexed for MEDLINE]Related articles

    10.

    Telmisartan improves endothelial function in patients with essential hypertension.

    Benndorf RA, Appel D, Maas R, Schwedhelm E, Wenzel UO, Böger RH.

    J Cardiovasc Pharmacol. 2007 Oct;50(4):367-71.PMID: 18049303 [PubMed - indexed for MEDLINE]Related articles

    11.

    Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone.

    Derosa G, Fogari E, D'Angelo A, Cicero AF, Salvadeo SA, Ragonesi PD, Ferrari I, Gravina A, Fassi R, Fogari R.

    J Clin Pharm Ther. 2007 Jun;32(3):261-8.PMID: 17489878 [PubMed - indexed for MEDLINE]Related articles

    12.

    Molecular detection of exercise-induced free radicals following ascorbate prophylaxis in type 1 diabetes mellitus: a randomised controlled trial.

    Davison GW, Ashton T, George L, Young IS, McEneny J, Davies B, Jackson SK, Peters JR, Bailey DM.

    Diabetologia. 2008 Nov;51(11):2049-59. Epub 2008 Sep 4.PMID: 18769906 [PubMed - indexed for MEDLINE]Related articles

    13.

    Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus.

    Schäfer A, Flierl U, Vogt C, Menninger S, Tas P, Ertl G, Bauersachs J.

    Pharmacol Res. 2007 Sep;56(3):217-23. Epub 2007 Jun 19.PMID: 17669665 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of telmisartan on forearm postischemic hyperemia and serum asymmetric dimethylarginine levels.

    Tomiyama H, Yamada J, Koji Y, Shiina K, Yoshida M, Yamashina A.

    Am J Hypertens. 2007 Dec;20(12):1305-11.PMID: 18047921 [PubMed - indexed for MEDLINE]Related articles

    15.

    Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients.

    Usui I, Fujisaka S, Yamazaki K, Takano A, Murakami S, Yamazaki Y, Urakaze M, Hachiya H, Takata M, Senda S, Iwata M, Satoh A, Sasaoka T, Ak ND, Temaru R, Kobayashi M.

    Diabetes Res Clin Pract. 2007 Aug;77(2):210-4. Epub 2007 Jan 19.PMID: 17240472 [PubMed - indexed for MEDLINE]Related articles

    16.

    Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spontaneously Diabetic Torii rats.

    Hasegawa G, Fukui M, Hosoda H, Asano M, Harusato I, Tanaka M, Shiraishi E, Senmaru T, Sakabe K, Yamasaki M, Kitawaki J, Fujinami A, Ohta M, Obayashi H, Nakamura N.

    Eur J Pharmacol. 2009 Mar 1;605(1-3):164-9. Epub 2009 Jan 10.PMID: 19171132 [PubMed - indexed for MEDLINE]Related articles

    17.

    The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control.

    Yamana A, Arita M, Furuta M, Shimajiri Y, Sanke T.

    Diabetes Res Clin Pract. 2008 Oct;82(1):127-31. Epub 2008 Aug 9.PMID: 18692932 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients.

    Ceriello A, Assaloni R, Da Ros R, Maier A, Piconi L, Quagliaro L, Esposito K, Giugliano D.

    Circulation. 2005 May 17;111(19):2518-24. Epub 2005 May 2.PMID: 15867169 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C.

    Antoniades C, Tousoulis D, Tountas C, Tentolouris C, Toutouza M, Vasiliadou C, Tsioufis C, Toutouzas P, Stefanadis C.

    Diabet Med. 2004 Jun;21(6):552-8.PMID: 15154938 [PubMed - indexed for MEDLINE]Related articles

    20.

    Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.

    Novelli M, D'Aleo V, Lupi R, Paolini M, Soleti A, Marchetti P, Masiello P.

    Pancreas. 2007 Nov;35(4):e10-7.PMID: 18090226 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity